COCH (STOCKS)
Envoy Medical, Inc. Class A Common Stock
$0.636000
+0.024000 (+3.92%)
Prev close: $0.612000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Brent T. Lucas
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $49.06M
- Employees
- 42
- P/E (TTM)
- -0.51
- P/B (TTM)
- -1.51
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.34 | $-0.32 | -0.0238 | -7.53% |
|
Jun 2025 (Q2)
|
$-0.32 | $-0.32 | -0.0038 | -1.20% |
|
Mar 2025 (Q1)
|
$-0.29 | $-0.35 | +0.0568 | +16.38% |
|
Dec 2024 (Q4)
|
$-0.46 | $-0.33 | -0.1302 | -39.48% |
Financial Statements
| Revenues | $241.00K |
| Benefits Costs and Expenses | $24.00M |
| Cost Of Revenue | $874.00K |
| Costs And Expenses | $22.51M |
| Gross Profit | -$633.00K |
| Nonoperating Income/Loss | -$1.49M |
| Operating Expenses | $21.64M |
| Research and Development | $12.49M |
| Other Operating Expenses | $9.15M |
| Operating Income/Loss | -$22.27M |
| Income/Loss From Continuing Operations After Tax | -$23.76M |
| Income/Loss From Continuing Operations Before Tax | -$23.76M |
| Net Income/Loss | -$23.76M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$23.76M |
| Net Income/Loss Available To Common Stockholders, Basic | -$28.66M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $4.91M |
| Preferred Stock Dividends And Other Adjustments | $4.91M |
| Basic Earnings Per Share | -$1.23 |
| Diluted Earnings Per Share | -$1.23 |
| Basic Average Shares | 23,259,598 |
| Diluted Average Shares | 23,259,598 |
| Assets | $8.56M |
| Current Assets | $6.28M |
| Inventory | $1.55M |
| Other Current Assets | $4.73M |
| Noncurrent Assets | $2.28M |
| Fixed Assets | $1.04M |
| Other Non-current Assets | $1.24M |
| Liabilities | $20.33M |
| Current Liabilities | $11.56M |
| Accounts Payable | $2.92M |
| Other Current Liabilities | $8.64M |
| Noncurrent Liabilities | $8.76M |
| Equity | -$12.16M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$12.16M |
| Temporary Equity | $391.00K |
| Temporary Equity Attributable To Parent | $391.00K |
| Liabilities And Equity | $8.56M |
| Net Cash Flow From Operating Activities | -$18.20M |
| Net Cash Flow From Operating Activities, Continuing | -$18.20M |
| Net Cash Flow From Investing Activities | -$179.00K |
| Net Cash Flow From Investing Activities, Continuing | -$179.00K |
| Net Cash Flow From Financing Activities | $16.63M |
| Net Cash Flow From Financing Activities, Continuing | $16.63M |
| Exchange Gains/Losses | $3.00K |
| Net Cash Flow | -$1.74M |
| Net Cash Flow, Continuing | -$1.75M |
| Comprehensive Income/Loss | -$23.75M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$23.75M |
| Other Comprehensive Income/Loss | $3.00K |